FASTKD2

Chr 2AR

FAST kinase domains 2

Also known as: COXPD44, KIAA0971

This gene encodes a protein that is localized in the mitochondrial inner compartment and that may play a role in mitochondrial apoptosis. Nonsense mutations have been reported to result in cytochrome c oxidase deficiency. [provided by RefSeq, Oct 2008]

GeneReviewsOMIMResearchGenerating clinical summary…
MultiplemechanismARLOEUF 0.751 OMIM phenotype
Clinical SummaryFASTKD2
🧬
Gene-Disease Validity (ClinGen)
mitochondrial disease · ARDefinitive

Definitive — sufficient evidence for diagnostic panels

Population Constraint (gnomAD)
Low constraint (pLI 0.00) — loss-of-function variants are relatively tolerated in the population.
📋
ClinVar Variants
33 unique Pathogenic / Likely Pathogenic· 297 VUS of 532 total submissions
📖
GeneReview available — FASTKD2
Authoritative clinical overview · Recommended first read
Open GeneReview ↗

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

Tolerant — LoF & missense variants common in population
LoF Constraint?
0.75LOEUF
pLI 0.000
Z-score 2.60
OE 0.48 (0.320.75)
Tolerant

Typical tolerance to LoF variation

Missense Constraint?
0.67Z-score
OE missense 0.90 (0.820.99)
328 obs / 363.7 exp
Tolerant

Mild missense constraint

Observed / Expected Ratios?
LoF OE?0.48 (0.320.75)
00.351.4
Missense OE?0.90 (0.820.99)
00.61.4
Synonymous OE?1.11
01.21.6
LoF obs/exp: 14 / 29.2Missense obs/exp: 328 / 363.7Syn Z: -0.97

This gene — mechanism propensity

DN
0.6647th %ile
GOF
0.6735th %ile
LOF
0.2582th %ile

This gene has evidence for multiple mechanisms of pathogenicity (gain-of-function and dominant-negative). Both the Badonyi & Marsh prediction and the broader genomic evidence point to gain-of-function as the predominant mechanism. Different variants in this gene may act through different mechanisms — interpret in context of the specific variant.

GOFprediction above median
DNprediction above median

Note: In-silico variant effect predictors (SIFT, PolyPhen, REVEL, CADD) may underestimate pathogenicity of missense variants in genes with GOF or DN mechanisms. Consider functional evidence and clinical context.

Predictions from Badonyi M, Marsh JA. PLoS ONE. 2024;19(8):e0307312.

ClinVar Variant Classifications

532 submitted variants in ClinVar

Classification Summary

Pathogenic14
Likely Pathogenic19
VUS297
Likely Benign128
Benign32
Conflicting27
14
Pathogenic
19
Likely Pathogenic
297
VUS
128
Likely Benign
32
Benign
27
Conflicting

Curated Variants Distribution

Classified variants from ClinVar · 5 ACMG categories

ClassificationLoFMissense + InframeNon-codingSynonymousTotal
Pathogenic
13
1
0
0
14
Likely Pathogenic
17
2
0
0
19
VUS
1
190
101
5
297
Likely Benign
0
17
58
53
128
Benign
0
1
30
1
32
Conflicting
27
Total3121118959517

LoF = frameshift, stop gained/lost, canonical splice · Counts from ClinVar esearch · Updated hourly

View in ClinVar →

26 pathogenic / likely-pathogenic (of 29) ClinVar copy-number / structural variants overlap FASTKD2 — these span large chromosomal regions, not the gene specifically, and are excluded from the counts above. Explore in CNV tools →

Protein Context — Lollipop Plot

FASTKD2 · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

Clinical Trials

Active and recruiting trials from ClinicalTrials.gov

No active trials found for this gene.

Search ClinicalTrials.gov →